Hartkopf AD - Search Results

1

Hartkopf AD, Fehm T, Wallwiener D, Lauer UM. Hartkopf AD, et al. Gynecol Oncol. 2011 Oct;123(1):164-71. doi: 10.1016/j.ygyno.2011.06.021. Epub 2011 Jul 20. Gynecol Oncol. 2011. PMID: 21764108 Review.

2

Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.

Geletneky K, Hartkopf AD, Krempien R, Rommelaere J, Schlehofer JR. Geletneky K, et al. Among authors: hartkopf ad. J Biomed Biotechnol. 2010;2010:350748. doi: 10.1155/2010/350748. Epub 2010 Mar 7. J Biomed Biotechnol. 2010. PMID: 20224643 Free PMC article.

3

The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service.

Wallwiener M, Wallwiener CW, Brucker SY, Hartkopf AD, Fehm TN, Kansy JK. Wallwiener M, et al. Among authors: hartkopf ad. BMC Cancer. 2010 Dec 2;10:663. doi: 10.1186/1471-2407-10-663. BMC Cancer. 2010. PMID: 21126358 Free PMC article.

4

Oncolytic virotherapy of gynecologic malignancies.

Hartkopf AD, Fehm T, Wallwiener D, Lauer U. Hartkopf AD, et al. Gynecol Oncol. 2011 Feb;120(2):302-10. doi: 10.1016/j.ygyno.2010.10.031. Epub 2010 Dec 8. Gynecol Oncol. 2011. PMID: 21145097 Review.

5

[Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma].

Schilling D, Todenhöfer T, Taran FA, Hartkopf A, Stenzl A, Fehm T. Schilling D, et al. Aktuelle Urol. 2011 Mar;42(2):122-7. doi: 10.1055/s-0031-1271391. Epub 2011 Mar 24. Aktuelle Urol. 2011. PMID: 21437836 German.

6

Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.

Hartkopf AD, Wagner P, Wallwiener D, Fehm T, Rothmund R. Hartkopf AD, et al. Anticancer Res. 2011 Mar;31(3):979-84. Anticancer Res. 2011. PMID: 21498725

7

Differential mRNA expression of TACR1 after ischemic peritoneal trauma: a pilot animal study.

Kraemer B, Wallwiener M, Wallwiener CW, Juhasz-Boess I, Hartkopf A, Wallwiener D, Rajab TK. Kraemer B, et al. Arch Gynecol Obstet. 2012 Mar;285(3):717-20. doi: 10.1007/s00404-011-2041-4. Epub 2011 Aug 12. Arch Gynecol Obstet. 2012. PMID: 21837425

8

Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread.

Hartkopf AD, Banys M, Krawczyk N, Staebler A, Becker S, Hoffmann J, Hahn M, Wallwiener M, Fehm T. Hartkopf AD, et al. Breast Cancer Res Treat. 2012 Jan;131(2):501-8. doi: 10.1007/s10549-011-1802-x. Epub 2011 Oct 5. Breast Cancer Res Treat. 2012. PMID: 21971730

9

Clinical implications of the detection of circulating tumor cells in breast cancer patients.

Banys M, Hartkopf AD, Krawczyk N, Becker S, Fehm T. Banys M, et al. Among authors: hartkopf ad. Biomark Med. 2012 Feb;6(1):109-18. doi: 10.2217/bmm.11.106. Biomark Med. 2012. PMID: 22296204 Review.

10

HER2-positive DTCs/CTCs in breast cancer.

Hartkopf AD, Banys M, Fehm T. Hartkopf AD, et al. Recent Results Cancer Res. 2012;195:203-15. doi: 10.1007/978-3-642-28160-0_19. Recent Results Cancer Res. 2012. PMID: 22527508 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters